FindTrial
Sign In

Effect of 'Misatol GL(MK615)' on nonalcoholic steatohepatitis(NASH):multicenter exploratory study

Effect of 'Misatol GL(MK615)' on nonalcoholic steatohepatitis(NASH):multicenter exploratory study - Effect of 'Misatol GL(MK615)' on NASH

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015540
Enrollment
15
Registered
2014-10-28
Start date
2014-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic steatohepatitis(NASH)

Interventions

administration of misatol

Sponsors

Division of Gastroenterology, Takasaki General Medical Center
Lead Sponsor
Division of Gastroenterology, Kusunoki Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)The patient diagnosed as NASH from biopsy examination. 2)The patients with the level of ALT over 60U/ml

Exclusion criteria

Exclusion criteria: 1)The patient who was diagnosed as an inappropriate one by the researcher.

Design outcomes

Primary

MeasureTime frame
Change of ALT levels—

Countries

Japan

Contacts

Public ContactTakashi Hoshino

National Hospital Organization, Takasaki General Medical Center Division of Gastroenterology

fwnx6146@yahoo.co.jp027-322-5901

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026